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Background. Chronic respiratory symptoms are common among children living with human immunodeficiency virus (HIV). 
We investigated the radiological features of chronic lung disease in children aged 6–16 years receiving antiretroviral therapy for 
≥6 months in Harare, Zimbabwe.
Methods. Consecutive participants from a HIV clinic underwent clinical assessment and chest radiography. Participants with an 
abnormal chest radiograph (assessed by a clinician) and/or those meeting a clinical case definition for chronic lung disease under-
went high-resolution computed tomography (HRCT). Radiological studies were scored independently and blindly by 2 thoracic 
radiologists. Relationships between radiological abnormalities and lung function were examined.
Results. Among 193 participants (46% female; median age, 11.2 years; interquartile range, 9.0–12.8 years), the median CD4 cell 
count was 720/µL (473–947/µL), and 79% had a human immunodeficiency virus (HIV) load of <400 copies/mL. The most common 
chest radiographic finding was ring/tramline opacities (55 of 193 participants; 29%). HRCT scans were evaluated in 84 participants 
(69%); decreased attenuation (present in 43%) was the dominant abnormality seen. The extent of decreased attenuation was strongly 
correlated with both the severity and extent of bronchiectasis (rs = 0.68 and P <  .001 for both). The extent of decreased attenu-
ation was also negatively correlated with forced expiratory volume in first second of expiration (rs = –0.52), forced vital capacity 
(rs = –0.42), and forced expiratory flow, midexpiratory phase (rs = –0.42) (P < .001 for all).
Conclusions. The HRCT findings strongly suggest that obliterative bronchiolitis may be the major cause of chronic lung disease 
in our cohort. Further studies to understand the pathogenesis and natural history are urgently needed.
Keywords. Sub-Saharan Africa; HIV; chronic lung disease; HRCT; chest X-ray. 
The global scale-up of antiretroviral therapy (ART) has resulted 
in a substantial decline in the incidence of perinatally acquired 
infections, and in a dramatic improvement in survival of chil-
dren with human immunodeficiency virus (HIV) infection [1]. 
Hence, children with HIV who would otherwise have died in 
infancy, are now reaching adolescence in large numbers, and the 
pediatric HIV epidemic has shifted from one characterized by 
very high early childhood mortality rates to one that is a chronic, 
treatable condition among older children and adolescents [2].
Cotrimoxazole prophylaxis and ART substantially reduce the 
risk of acute respiratory tract infections and tuberculosis [3, 4]. 
However, recent studies from sub-Saharan Africa have reported 
a high prevalence of chronic lung disease, even among older 
children receiving ART [5–7]. The typical clinical picture is of 
a chronic, usually nonproductive, cough, hypoxia, tachypnea, 
reduced exercise tolerance and decreased lung function, and 
“nonspecific” chest radiographic abnormalities [8]. Plain chest 
radiography, despite its ready availability, is insensitive, and ter-
minology used to define abnormalities often inconsistent. The 
limited availability of diagnostic modalities in resource-limited 
settings hinders definitive diagnosis and, in the absence of an 
alternative diagnoses, presumptive tuberculosis treatment is 
often started for those with chronic respiratory symptoms [9].
We recently conducted a prospective study to investigate the 
prevalence of chronic respiratory disease in HIV-infected chil-
dren and adolescents attending for routine HIV care who were 
well established on ART and receiving cotrimoxazole proph-
ylaxis. Among these children, 25% had chronic respiratory 
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symptoms and reduced lung function [10]. In the present study, 
we report the spectrum of abnormalities on high-resolution 
computed tomography (HRCT) among study participants and 
association of radiological abnormalities with lung function.
METHODS
Study Participants
HIV-infected children aged 6–16  years receiving routine out-
patient HIV care at the Harare Central Hospital, the largest 
public-sector hospital in Harare, Zimbabwe, were consecutively 
recruited, with enrollment limited to the first 5 eligible children 
every weekday for logistical ease. Recruitment was limited to 
those receiving ART (first or second line) for ≥6 months. The 
6-month cutoff for ART duration was selected to allow enough 
time for participants to achieve viral suppression and for 
immune reconstitution inflammatory syndrome to manifest, 
which usually occurs in the first few months after ART initi-
ation. Children with tuberculosis (excluded through sputum 
smear and culture examination) or presenting with symptoms 
and signs of acute respiratory tract infection were excluded.
The study was approved by the Medical Research Council 
of Zimbabwe, the Harare Hospital Ethics Committee, the 
Biomedical Research and Training Institute Institutional Review 
Board, and the London School of Hygiene and Tropical Medicine 
Ethics Committee. Written informed consent from guardians 
and assent from children was obtained before enrollment.
Data Collection
Study procedures are described in detail elsewhere [10]. Briefly, 
sociodemographic and clinical data including HIV treatment his-
tory, past illnesses, and current symptoms were collected through 
a nurse-administered questionnaire. Participants underwent a 
standardized clinical examination, including pulse oximetry, shut-
tle walk testing, and spirometry. Spirometry was performed using 
EasyOne World spirometers (ndd Medical Technologies), follow-
ing American Thoracic Society standard procedures [11]. Up to 
8 forced exhalations were recorded with patients sitting, and the 
only data analyzed were from individuals who produced 3 con-
sistent traces that met American Thoracic Society quality criteria. 
The highest forced expiratory volume in first second of expiration 
(FEV1) and forced vital capacity measurements were used, with 
other indices recorded from the best trace (largest total of FEV1 
and forced vital capacity). Normal spirometric ranges were defined 
using the GLI 2012 equation, which gives reference values specific 
for race and sex and takes into account height and age [12]. The 
lower limit of normal was defined as 1.64 standard deviations (SDs) 
below the mean expected value (which describes the lowest 10 cen-
tiles of the reference population as “abnormal”). CD4 cell counts 
were determined using the PIMA platform (Alere), and HIV load 
by means of the COBAS Ampliprep/Taqman 48 analyzer (Roche).
Study participants underwent standard posteroanterior plain 
chest radiography. Participants referred for HRCT of the chest 
included those with an abnormal chest radiograph (assessed 
initially by a respiratory physician, blinded to clinical data) and 
those meeting the clinical case definition of chronic lung dis-
ease (ie, the presence of ≥1 of the following: chronic cough for 
≥1 month with no microbiological evidence of tuberculosis; 
oxygen saturation of <92% at rest or desaturation of ≥5% from 
baseline on exercise testing; Medical Research Council (MRC) 
dyspnea score of >1; resting tachypnea [respiratory >30/min for 
6–12-year-olds or >24/min for 13–16-year-olds); and abnormal 
results of spirometry, as defined above.
Supine HRCT images (1-mm collimation with 10-mm inter-
spacing) were acquired at full inspiration and reconstructed 
using a high-spatial-frequency lung algorithm with window 
settings appropriate for viewing the lung parenchyma (window 
centre, −550 HU; window width, 1500 HU). HRCT studies were 
anonymized and downloaded onto digital storage disks for sub-
sequent review on high-resolution screens using an Osirix HD 
viewing platform (OsiriX, version 6.5.2; OsiriX Foundation). The 
chest radiographic and HRCT studies were scored independently 
and in separate sessions by 2 thoracic radiologists blinded to clin-
ical data (S. R. D. and A. N., with 20 and 11 years’ experience 
respectively in the interpretation of thoracic imaging).
Chest Radiographic and HRCT Scoring
Principal chest radiographic and HRCT patterns were defined 
according to the Fleischner Society Glossary of terms [13]. Chest 
radiographic abnormalities were quantified using a previously 
validated scoring system with low interobserver variability [14]. 
In brief, the overall extent of abnormal lung (irrespective of pat-
tern) was graded semiquantitatively on a 5-point scale (0, nor-
mal lung; 1–4, 1%–25%, 26%–50%, 51%–75%, and 76%–100% 
abnormal lung, respectively). The proportional extents of the 
following principal radiographic patterns were then quanti-
fied: consolidation; reticular pattern; noncavitating nodules; 
cavitating nodules; ring and/or tramline opacities (reflecting 
the presence of thick-walled and/or dilated bronchi seen either 
“end-on” [rings] or in plane [tramlines]; ground-glass opaci-
fication; and masses. Nonprincipal patterns—namely, paucity 
of vessels, hilar and/or mediastinal lymph node enlargement, 
and hyperexpansion—were recorded as absent or present. The 
severity of volume loss, if present, was graded semiquantita-
tively (0, no volume loss; 1, mild; 2, severe).
HRCT patterns were quantified visually in 6 lobes (note that 
the lingula was considered as a separate lobe). The lobar extent/
severity of the following HRCT abnormalities were scored sem-
iquantitatively [15, 16]: (1) the extent of bronchiectasis (0,  no 
bronchiectasis; 1, bronchiectasis in 1 or part of 1 bronchopul-
monary segment; 2,  bronchiectasis in >1 bronchopulmonary 
segment; and 3,  generalized bronchiectasis); (2) the severity 
of bronchiectasis (0, no airway dilatation; 0.5, trivial dilatation 
compared with the transverse diameter of the homologous pul-
monary artery; 1,  100%–200% of that diameter; and 2,  more 
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than 200%–300% of that diameter); (3) the severity of bronchial 
wall thickening (0,  no discernible wall thickening; 0.5,  triv-
ial wall thickening; 1,  <50% of the transverse diameter of the 
homologous pulmonary artery; 2, 50%–100% of the transverse 
diameter of the accompanying pulmonary artery); (4) the extent 
of centrilobular (small airway); (5) large-airway mucus plugging 
(both similarly scored as follows: 0, no plugging; 1, plugging in 1 
or part of 1 bronchopulmonary segment; 2, plugging in >1 bron-
chopulmonary segment; and 3, generalized plugging in all bron-
chopulmonary segments); (6) the severity of lobar volume loss 
(0, no volume loss; 1, mild volume loss; and 2, marked volume 
loss). Thus, the maximal expressible score for each of the extent 
of bronchiectasis, small-airway plugging, and large-airway plug-
ging was 18, and the maximal score for severity of bronchiec-
tasis, bronchial wall thickening and volume loss was 12.
After semiquantitative evaluation, the overall extent of abnormal 
lung in each lobe (to the nearest 5%) and the proportional extents 
of the following HRCT patterns (totaling 100%) were quantified: 
consolidation, a reticular pattern, ground-glass opacification, 
decreased attenuation (as a component of the mosaic attenuation 
pattern), emphysema, and pulmonary air cysts and nodules, with 
or without cavitation. Discrepant observations for the presence or 
absence of the radiological patterns and their distribution were 
resolved by consensus review. The threshold for consensus was a 
difference in proportional extent of abnormalities of >20%.
Statistical Analysis
Data were extracted from paper-based questionnaires by optical 
character recognition (Cardiff Teleform Intelligent Character, 
version 10.7), and analyzed using Stata software (version 
12; (=StataCorp). Data were expressed as means  with SDs or 
medians with interquartile range (IQR) or range, as appropri-
ate. A  height-for-age and weight-for age z score of ≤2, based 
on World Health Organization reference standards, was used to 
define stunting and wasting, respectively [17]. For chest radiog-
raphy, the score for each pattern was recorded as a mean value 
of both observers’ scores. Similarly, for the 6 semiquantitatively 
scored HRCT abnormalities, the lobar scores for each observer 
were first summed, and the average for the 2 observers was then 
calculated. Because the maximal expressible scores for the sem-
iquantitative variables differed, the semiquantitative data were 
linearly transformed into a percentage scale, wherein 0 rep-
resented normal appearances, and 100 the maximal extent of 
abnormality, to homogenize the scores [18]. Thus, for example, 
a patient with a bronchiectasis extent score of 6 and a bronchi-
ectasis severity score of 6 would have his or her scores expressed 
as 6/18 × 100 = 33.3 and 6/12 × 100 = 50.0, respectively. 
For the total extent of abnormality and the proportional extent 
of the 8 CT patterns assessed, the post-consensus lobar scores 
for each observer were first summed, divided by 6 to obtain a 
mean lobar score, and the average lobar score for the 2 observers 
was then calculated. Observer agreement data for quantifying 
the extent/severity of chest radiographic and HRCT patterns was 
assessed using the weighted quadratic Cohen’s kappa value (κω) 
for ordinal variables or the single-determination (SD) [19] for 
continuous variables as appropriate. Agreement was categorized 
as poor (κω, 0 to ≤0.20), fair (0.20 to ≤0.40), moderate (0.40 to 
≤0.60), good (0.60 to ≤0.80), or excellent (0.80 to ≤1.00) [19]. 
The association between common HRCT patterns (>10% prev-
alence) and between HRCT patterns and FEV1 was examined 
using Spearman rank correlation coefficients (rs).
RESULTS
Of the 202 participants recruited into the study, 193 had chest 
radiographic data available; the median age of participants was 
11.2 years (IQR, 9.0–12.8) years, and 46% were female. The 
median duration of ART was 4.8 years (IQR, 2.6–6.4) and 79% 
had an HIV load <400 copies/mL. The chest radiograph was 
assessed as abnormal by the respiratory physician in 44% of 
participants and by the thoracic radiologists in 33% (64 of 193). 
The most common principal abnormality was ring/tramline 
opacities (seen in 28% of participants), followed by consolida-
tion (seen in 7%). Other patterns were uncommon (Table 1).
Overall, 121 participants (63%) were eligible for HRCT scan-
ning owing either to abnormal clinical findings or to an abnor-
mal chest radiograph (Figure 1). Of these, 89 (74%) underwent 
HRCT scanning (the remainder not attending for their appoint-
ment), of whom 5 were excluded because of image degradation 
by breathing artifact. Among those eligible for HRCT, there 
were no differences between those who did and those who did 
not undergo HRCT in age or sex, duration of ART, proportion 
with viral suppression, or proportion with respiratory symp-
toms and signs. Clinical findings are summarized in Table 2 but 
are discussed in detail elsewhere [10].
Table 1. Prevalence and Extent of Chest Radiographic Abnormalities
Abnormality
Participants, No. (%)
Prevalence of 
Abnormality
With >25% Extent of 
Abnormalitya
Principle patterns
 Rings or tramlines 55 (28) 54 (98)
 Consolidation 14 (7) 10 (71)
 Ground-glass pattern 10 (5) 7 (70)
 Reticulation 1 (0.5) 0 (0)
 Noncavitating nodules 3 (2) 3 (100)
 Cavitating nodules 0 …
 Mass 0 …
Nonprincipal patterns
 Volume loss 10 (5) NA
 Hyperexpansion 4 (2) NA
 Lymph nodes 8 (4) NA
 Paucity of markings 3 (2) NA
Abbreviation: NA, not applicable.
aGiven as a percentage of those exhibiting the abnormality.
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HRCT abnormalities were present in 70 of 84 participants (83%); 
the chest radiograph was normal in 39 participants (56%) with 
HRCT abnormalities. The most common HRCT abnormality was 
bronchial wall thickening, observed in 82% of HRCT scans, but this 
was of trivial severity in the majority (Tables 3 and 4). Decreased 
attenuation, as part of a mosaic attenuation pattern, was present 
in 43% of scans; 35 of the 36 scans with decreased attenuation had 
>5% extent of the pattern (Figure 2). Bronchiectasis, lobar volume 
loss, and large- or small-airway plugging were seen in 33%, 29%, 
and 26% respectively, and emphysema in 7%. Consolidation (2%), 
reticulation (1%), ground-glass opacification (1%), and pulmonary 
air cysts (1%) were uncommon HRCT findings.
The extent of decreased attenuation, as a component of the 
mosaic attenuation pattern, was strongly correlated with the 
extent of bronchiectasis (rs = 0.68; P < .001) and the severity of 
bronchial wall thickening (rs = 0.63; P < .001). There were weaker 
associations between the extent of decreased attenuation and 
plugging of large (rs = 0.40; P < .001) or small (rs = 0.38; P < .001) 
airways. The severity of bronchial wall thickening was also 
strongly correlated with the extent of bronchiectasis (rs = 0.61; 
Enrolled (n = 202)
Complete CXR and clinical data (n = 193)
No CXR available
(n = 9)
Abnormal CXR with or without
fulfillment of
clinical case definition
(n = 84)
Fulfilling clinical case
definition; normal CXR
(n = 37)
Normal CXR and no abnormal
clinical findings (n = 72)
Desaturation on exercise
(n = 8)
Abnormal CXR only
(n = 40)
Normal CXR but abnormal
spirometry (n = 6)
Abnormal CXR + spirometry
(n = 13)
Normal CXR but chronic
cough (n = 6)
Abnormal CXR + chronic
cough (n = 4)
Normal CXR but MRC
dyspnea score score>2
(n = 4)
Abnormal CXR +
desaturation on exercise
(n = 4)
Abnormal CXR +
abnormal spirometry results,
O2 saturation <92%,
chronic cough, and/or
MRC dyspnea score >1
(n = 13)
Abnormal CXR +
abnormal spirometry results,
O2 saturation <92%,
chronic cough, and/or
MRC dyspnea score >1
(n = 23)
HRCT findings
Abnormal (n = 56)
Normal (n = 7)
Uninterpretable (n = 3)
No HRCT done (n = 18)
HRCT findings
Abnormal (n = 17)
Normal (n = 4)
Uninterpretable (n = 2)
No HRCT done (n = 14)
Figure 1. Flow chart of study participants. Abbreviations: CXR, chest radiography; HRCT, high-resolution computed tomography; MRC, Medical Research Council; O2, 
oxygen.
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P < .001) and with plugging of large (rs = 0.49; P < .001) or small 
(rs = 0.50; P < .01) airways. Decreased attenuation and the extent 
of bronchiectasis were strongly correlated with FEV1 (rs = −0.52; 
P < .001 and rs = −0.50; P < .001 respectively) (Table 5).
Observer variability for quantifying the extent of abnormal 
lung on chest radiographs was moderate (κω = 0.56) (Tables 6 
and 7). Observer agreement for semiquantitative HRCT abnor-
malities was moderate to good, and the single-determination 
SD for the 7 continuous HRCT variables ranged from 5.8% for 
consolidation to 31.0% for decreased attenuation.
DISCUSSION
Our study shows that there is a high prevalence of lung disease in 
HIV-infected children receiving ART. The most common abnor-
mality on plain chest radiographs were ring and tramline opacities, 
suggestive of airway inflammation. However, HRCT is the imaging 
modality of choice for the investigation of small- and large-airway 
disease. The principal HRCT abnormality were regions of decreased 
attenuation admixed with lung of normal density, the “mosaic 
attenuation pattern.” Because of its lower contrast resolution, the 
mosaic pattern is not seen on chest radiographs. By contrast, HRCT 
is exquisitely sensitive to any alteration in density, which, for the lung 
parenchyma, is strictly governed by the amount of air. Any change in 
the relative proportion of air, whether this is physiological (as is seen 
during normal breathing) or pathological (as might occur with any 
infiltrative disease; with impaired ventilation caused by small-air-
way disease and specifically, obliterative bronchiolitis [OB]; or 
with altered perfusion [eg, chronic thromboembolic disease]), will 
increase or decrease parenchymal attenuation [20].
In our patients, there was no clinical evidence of an infiltrative 
disease, such as infection of pulmonary edema. Moreover, the 
strong association between the extent of decreased attenuation 
and indices of airflow obstruction (FEV1 and forced expiratory 
flow, midexpiratory phase), without reversibility, makes chronic 
thromboembolic disease highly unlikely and instead supports 
Table 2. Characteristics of Study Participants Undergoing Chest 
Radiography and High-Resolution Computed Tomography
Characteristic
Participants, No. (%)a
Undergoing Chest 
Radiography 
(n = 193)
Undergoing 
HRCT
(n = 84)
Female sex 89 (46) 44 (52)
Age, median (IQR), y 11.2 (9.0–12.8) 11.6 (9.6–13.6)
Age at diagnosis, median (IQR), y 4.9 (2.7–7.5) 5.5 (3.3–8.5)
Duration of ART, median (IQR), y 4.8 (2.6–6.4) 4.7 (2.7–6.6)
CD4 cell count, median (IQR), cells/µL 720 (473–947) 686 (447–887)
HIV load <400 copies/mL 150 (79)b 64 (77)c
Any respiratory symptom 51 (26) 32 (38)
MRC dyspnea score >1 22 (11) 15 (18)
Daily cough for >1 mo 30 (16) 21 (25)
Daily cough for >1 mo with sputum 18 (12) 13 (15)
Wheezing 9 (5) 4 (5)
Household member who is a smoker 42 (22) 23 (27)
Height-for age z score ≤2 69 (36) 32 (38)
Weight-for age z score ≤2 18 (9) 9 (11)
Known history of asthma 7 (4) 2 (2)
History of Pneumocystis jirovecii 6 (3) 1 (1)
Previously treated for tuberculosis 74 (38) 34 (40)
Tachypnea (respiratory rate >30/min at 
rest for age 6–12 y or >24/min for 
age 13–16 y)
12 (6) 6 (7)
Abnormal SpO2 (resting hypoxia <92% 
or desaturation >5% with exercise)
23 (12) 15 (18)
Abnormal results of spirometryd 40 (24) 27 (37)
Obstructive pattern at spirometry 7 (5)e 5 (10)f
Chest radiograph identified as abnormal 
by respiratory physician
84 (43) …
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; IQR, inter-
quartile range; MRC, Medical Research Council; SpO2, oxygen saturation.
aData represent No. (%) of participants unless otherwise specified.
bViral load data were missing in 3 participants. 
cViral load data were missing in 2 participants.
dSpirometric results were of acceptable quality for 127 participants in the chest radiography 
group and 73 in the HRCT subgroup.
eSpirometric data available in 136 individuals. 
fSpirometric data available in 51 individuals.
Table 3. Prevalence and Extent/Severity of High-Resolution Computed 
Tomographic Scan Abnormalities
HRCT Pattern
Participants, No. (%)
Prevalence 
of Pattern
Relative Proportion of Severitya 
0 < Score < 25 25 < Score < 50 Score ≥50
Bronchiectasis 
extent
28 (33) 19 (68) 8 (29) 1 (4)
Bronchiectasis 
severity
NA 17 (61) 9 (32) 2 (7)
Bronchial wall 
thickening
69 (82) 51 (74) 16 (23) 2 (3)
Small-airway 
plugging
12 (14) 12 (100) 0 (0) 0 (0)
Large-airway 
plugging
10 (12) 7 (70) 3 (30) 0 (0)
Lobar volume 
loss
24 (29) 22 (92) 1 (4) 1 (4)
Abbreviation: NA, not applicable.
aPercentage of total with pattern.
Table 4. Proportional Extent of High-Resolution Computed Tomographic 
Scan Patterns
HRCT Pattern
Participants, No. (%)
Prevalence of Pattern Pattern of >5% HRCT Extenta
Consolidation 2 (2) 2 (100)
Reticulation 1 (1) 1 (100)
Ground-glass opacity 1 (1) 1 (100)
Decreased attenuation 36 (43) 35 (97)
Emphysema 6 (7) 6 (100)
Air cysts 1 (1) 1 (100)
Cavitating nodules 0 (0) 0 (0)
Noncavitating nodules 0 (0) 0 (0)
aGiven as a percentage of those exhibiting the HRCT pattern.
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OB as the likely cause of chronic lung disease in HIV-infected 
children. Importantly, there was a strong correlation between 
the extent of decreased attenuation and the extent of bronchiec-
tasis, again strongly supporting airway-based pathology.
Histopathological [21] and CT studies [22] have shown that 
bronchiectasis and OB frequently coexist. Moreover, studies in 
which HRCT patterns have been correlated with functional indi-
ces have shown that OB may precede the onset of bronchiectasis, as 
opposed to the suppuration and dilatation of the large airways lead-
ing to OB [22, 23]. Notably, our finding that OB is the likely major 
abnormality accounting for chronic lung disease contrasts sharply 
with findings from the pre-ART era, when lymphoid interstitial 
pneumonitis was the most common cause of chronic lung disease 
in children [24]. Lymphoid interstitial pneumonitis responds well 
to ART and corticosteroid treatment and is now uncommon [25].
It is important to appreciate that OB is not a diagnosis per 
se but a pathological lesion. Obliteration of the small air-
ways (defined arbitrarily as those with an internal diameter 
<2 mm) is a common incidental pathological finding [26, 
27]. The underlying mechanism is inflammation, which then 
causes partial or complete obliteration [28]. OB can occur as 
a sequel to diverse “insults,” including viral lower respiratory 
tract infections, connective tissue diseases, and exposure to 
toxic fumes, or as a manifestation of chronic graft-vs-host 
disease in recipients of heart-lung transplants [28]. A biopsy 
might be considered the reference standard for diagnosis, but 
the lesions of OB are patchily distributed and without metic-
ulous dissection; (compounded by issues of sampling error), 
the diagnosis is easily overlooked [29]. Furthermore, there 
is a high risk associated with performing an open (surgical) 
biopsy in children with already compromised respiratory 
function, particularly in low-resource settings. 
Chest radiography is widely available, of low cost, and has a rela-
tively low radiation dose, but it is an insensitive tool to identify OB: 
in our study, 56% of individuals with an abnormal HRCT scan had 
Figure 2. A, Chest radiograph of a participant scored as normal independently by both radiologists. B, High-resolution computed tomographic (HRCT) scan of the same 
patient, through the midzone demonstrating a striking mosaic pattern with areas of decreased attenuation adjacent to regions of normal lung density. C, HRCT scan of another 
patient, again showing regions of decreased attenuation as part of the mosaic pattern with cylindrical bronchiectasis in the middle lobe.
Table  5. Correlation Between High-Resolution Computed Tomographic 
Patterns and Lung Function (Indices of Airflow Limitation)
HRCT abnormality
Association With Lung Function, Spearman Rank 
Correlation Coefficient, rs (P Value)
FEV1 FVC FEF25%–75% FEV1/ FVC
Bronchiectasis 
extent
−0.50 (<.001) −0.36 (.002) −0.44 (<.001) −0.26 (.03)
Bronchiectasis 
severity
−0.49 (<.001) −0.36 (.002) −0.44 (<.001) −0.26 (.03)
Bronchial wall 
thickening
−0.43 (<.001) −0.34 (.003) −0.34 (.003) NS
Small-airway 
plugging
−0.40 (<.001) −0.33 (.005) −0.37 (.01) NS
Large-airway 
plugging
−0.42 (<.001) −0.38 (.001) −0.36 (.002) NS
Volume loss −0.38 (.001) −0.34 (.003) NS NS
Decreased 
attenuation
−0.52 (<.001) −0.42 (<.001) −0.42 (<.001) NS
Abbreviations: FEF25%–75%, forced expiratory flow, mid-expiratory phase; FEV1, forced expi-
ratory volume in first second of expiration; FVC, forced vital capacity; NS, not significant.
Table 6. Interobserver Agreement for Evaluation of Radiological Patterns 
at Chest Radiography and High-Resolution Computed Tomography: 
Continuous Variables
Pattern sdSD, %
Chest radiography
 Consolidation 19.7
 Ground-glass opacities 16.4
 Reticulation 1.0
 Noncavitating nodules 11.5
 Cavitating nodules 5.0
 Ring/tramline opacities 28.9
 Masses 0.0
HRCT 
 Overall extent 12.2
 Consolidation 5.8
 Ground-glass opacity 6.2
 Reticulation 5.6
 Decreased attenuation 31.0
 Emphysema 18.2
 Cysts 7.1
Abbreviations: NA, not applicable; sdSD, single-determination standard deviation.
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a normal chest radiograph. In addition, the 2-dimensional nature 
of the chest radiograph (leading to anatomic superimposition), and 
poor contrast resolution inevitably cause interpretative difficulties 
[30]. Therefore, HRCT coupled with lung function testing are 
probably the best noninvasive tests for a diagnosis of OB. 
However, owing to concerns about radiation dose, there is 
reluctance to perform HRCT studies in children. In addition, 
HRCT is not routinely available in resource-limited settings, 
which explains why this condition has not to date been iden-
tified in busy African HIV clinics. In the absence of alternative 
diagnoses, individuals with chronic symptoms are often treated 
presumptively for tuberculosis, a disease that is common in set-
tings with high HIV prevalence.
An interesting finding in our study was the presence of emphy-
sema (albeit of limited extent) in 7% of study participants. CT 
studies in a total of 1681 HIV-infected adults from 3 series [31–
33], have shown a prevalence of emphysema ranging from 19% 
to 53%. This large variation is, in part, almost certainly caused 
by different criteria for defining “significant” emphysema, and, 
even after controlling for smoking status, HIV was identified as 
an independent risk factor for emphysema [31].
There is a high reported prevalence of chronic lung disease, 
particularly airflow obstruction, among HIV-infected individu-
als, but mainly in high-income settings and among adults, where 
smoking and substance use is a major confounder. Importantly, 
none of the participants in our cohort had ever smoked, and 
biomass fuel use is relatively low in our setting, compared with 
other urban and periurban settings in sub-Saharan Africa [10, 
34, 35]. In addition, the prevalence of respiratory symptoms and 
poor lung function was substantially higher than in uninfected 
children of the same age group and socioeconomic status, as 
reported by Rylance et al [10]. The pathogenesis of chronic lung 
disease in HIV-infected children is not well understood but 
may be a long-term consequence of repeated respiratory tract 
infections or a direct consequence of HIV infection itself.
One strength of our study was that participants were not selected 
on the basis of symptoms. Subjects underwent HRCT scanning 
based on a predefined clinical case definition informed by previous 
studies that have shown a similar clinical picture in this age group 
[7]. In addition, radiological data was complemented by detailed 
clinical and lung function data. Furthermore, all radiological stud-
ies were scored independently by 2 experienced thoracic radiolo-
gists. A limitation of the study was that HRCT was performed only 
in participants who had clinical features of chronic lung disease 
or were assessed to have an abnormal chest radiograph, and some 
children with subclinical disease may have been missed, given the 
low sensitivity of chest radiography. HRCT scans were not available 
in 31% of participants. However, this was owing to participants not 
attending their scan appointments, and there was no difference in 
demographic or clinical features between those who did and did 
not attend. We were unable to measure lung diffusion capacity. 
There was some interobserver variation in scoring HRCT scans 
and chest radiographs, but this is within the range expected and 
both radiologists reached consensus on discrepant observations. It 
was not feasible to confirm our findings histologically. The study is 
cross-sectional, and therefore no causality can be attributed.
To our knowledge, ours is the first large prospective study of 
HRCT findings in HIV-infected older children and adolescents, 
and it demonstrated airway disease to be the major cause of 
chronic lung disease in this age group, in contrast to findings of 
lymphoid interstitial pneumonitis in the pre-ART era. Studies 
to elucidate the natural history and etiology are urgently needed 
so that therapeutic strategies can be developed.
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